世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
がん生物学的療法 - 世界市場シェアとランキング、全体売上高と需要予測 2024-2030Cancer Biological Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030 がん生物学的療法は、身体の免疫系を利用してがん細胞を死滅させる治療法の一種です。がん生物学的療法は、多くの種類のがんを治療することができます。腫瘍の成長を阻止したり遅らせたりして、がんの転移を予防... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリーがん生物学的療法は、身体の免疫系を利用してがん細胞を死滅させる治療法の一種です。がん生物学的療法は、多くの種類のがんを治療することができます。腫瘍の成長を阻止したり遅らせたりして、がんの転移を予防することができます。癌が広がることを転移性癌と呼ぶ。がん生物学的療法の世界市場は、2023年には100万米ドル規模になると推定され、2024〜2030年の予測期間中の年平均成長率は%で、2030年には100万米ドル規模に再調整されると予測されている。 癌生物学的療法の北米市場は、2023年に百万ドルと評価され、2024年から2030年の予測期間中に％のCAGRで、2030年までに百万ドルに達すると予測されています。 癌生物学的療法のアジア太平洋市場は、2023年に100万ドルと評価され、2024年から2030年の予測期間中に％のCAGRで、2030年までに100万ドルに達するだろう。 癌生物学的療法のヨーロッパ市場は、2023年に100万ドルと評価され、2024年から2030年の予測期間中に％のCAGRで、2030年までに100万ドルに達するだろう。 癌生物学的療法の世界の主要企業は、ELI Lilly、Sanofi、Merck、Bayer、Roche、Novartis International、Pfizer、Bristol-Myers Squibb、Seattle Geneticsなどである。2023年には、世界の大手5社が売上高で約 %のシェアを占めている。 レポートの範囲 本レポートは、癌生物学的療法の世界市場を包括的に紹介することを目的としており、癌生物学的療法の地域別・国別、タイプ別、用途別の分析とともに、総売上高、主要企業の市場シェア、ランキングに焦点を当てています。 がん生物学的療法の市場規模、推計、予測は、2023年を基準年として、2019年から2030年までの期間の履歴データと予測データを売上高（百万ドル）で提供します。定量分析および定性分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、がん生物学的療法に関する情報に基づいたビジネス上の意思決定を行うことを支援します。 市場区分 企業別 ELI リリー サノフィ メルク バイエル ロシュ ノバルティス ファイザー ブリストル・マイヤーズ スクイブ シアトルジェネティクス アムジェン 武田薬品工業 グラクソ・スミスクライン スペクトラム・ファーマシューティカルズ セルジーン・コーポレーション アストラゼネカ 大塚製薬 エーザイ アッヴィ インサイト タイプ別セグメント モノクローナル抗体 ワクチン がん成長阻害剤 血球成長因子 用途別セグメント 病院 診断研究所 研究機関 製薬・バイオテクノロジー企業 地域別 北米 米国 カナダ 欧州 ドイツ フランス 英国 イタリア ロシア アジア太平洋 中国 日本 韓国 中国 台湾 東南アジア インド ラテンアメリカ メキシコ ブラジル アルゼンチン 中東・アフリカ トルコ サウジアラビア アラブ首長国連邦 各章の概要 第1章：報告書のスコープ、世界の総市場規模を紹介します。本章ではまた、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界メーカーが直面する課題とリスク、業界の関連政策の分析を提供します。 第2章：がん生物学的療法メーカーの競争環境、収益市場シェア、最新の開発計画、合併・買収情報などを詳細に分析。 第3章：各種市場セグメントをタイプ別に分析し、各市場セグメントの市場規模と発展可能性を網羅し、読者が各市場セグメントにおけるブルーオーシャン市場を見つけやすくします。 第4章：用途別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性を網羅し、読者が異なる下流市場でブルーオーシャン市場を見つけるのを助ける。 第5章：地域レベルでのがん生物学的療法の収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来発展見込み、市場空間、市場規模を紹介しています。 第6章：国別がん生物学的療法の収益。各国・地域のタイプ別、用途別のシグメイトデータを提供。 第7章：主要企業のプロファイルを提供し、製品収益、売上総利益率、製品紹介、最近の開発など、市場における主要企業の基本的な状況を詳細に紹介する。 第8章：産業の上流と下流を含む産業チェーンの分析。 第9章：結論 目次1 Market Overview1.1 Cancer Biological Therapy Product Introduction 1.2 Global Cancer Biological Therapy Market Size Forecast 1.3 Cancer Biological Therapy Market Trends & Drivers 1.3.1 Cancer Biological Therapy Industry Trends 1.3.2 Cancer Biological Therapy Market Drivers & Opportunity 1.3.3 Cancer Biological Therapy Market Challenges 1.3.4 Cancer Biological Therapy Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Cancer Biological Therapy Players Revenue Ranking (2023) 2.2 Global Cancer Biological Therapy Revenue by Company (2019-2024) 2.3 Key Companies Cancer Biological Therapy Manufacturing Base Distribution and Headquarters 2.4 Key Companies Cancer Biological Therapy Product Offered 2.5 Key Companies Time to Begin Mass Production of Cancer Biological Therapy 2.6 Cancer Biological Therapy Market Competitive Analysis 2.6.1 Cancer Biological Therapy Market Concentration Rate (2019-2024) 2.6.2 Global 5 and 10 Largest Companies by Cancer Biological Therapy Revenue in 2023 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biological Therapy as of 2023) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Monoclonal Antibodies 3.1.2 Vaccines 3.1.3 Cancer Growth Blockers 3.1.4 Blood Cell Growth Factors 3.2 Global Cancer Biological Therapy Sales Value by Type 3.2.1 Global Cancer Biological Therapy Sales Value by Type (2019 VS 2023 VS 2030) 3.2.2 Global Cancer Biological Therapy Sales Value, by Type (2019-2030) 3.2.3 Global Cancer Biological Therapy Sales Value, by Type (%) (2019-2030) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Hospitals 4.1.2 Diagnostic Laboratories 4.1.3 Research & Academic Laboratories 4.1.4 Pharmaceutical & Biotechnology Companies 4.2 Global Cancer Biological Therapy Sales Value by Application 4.2.1 Global Cancer Biological Therapy Sales Value by Application (2019 VS 2023 VS 2030) 4.2.2 Global Cancer Biological Therapy Sales Value, by Application (2019-2030) 4.2.3 Global Cancer Biological Therapy Sales Value, by Application (%) (2019-2030) 5 Segmentation by Region 5.1 Global Cancer Biological Therapy Sales Value by Region 5.1.1 Global Cancer Biological Therapy Sales Value by Region: 2019 VS 2023 VS 2030 5.1.2 Global Cancer Biological Therapy Sales Value by Region (2019-2024) 5.1.3 Global Cancer Biological Therapy Sales Value by Region (2025-2030) 5.1.4 Global Cancer Biological Therapy Sales Value by Region (%), (2019-2030) 5.2 North America 5.2.1 North America Cancer Biological Therapy Sales Value, 2019-2030 5.2.2 North America Cancer Biological Therapy Sales Value by Country (%), 2023 VS 2030 5.3 Europe 5.3.1 Europe Cancer Biological Therapy Sales Value, 2019-2030 5.3.2 Europe Cancer Biological Therapy Sales Value by Country (%), 2023 VS 2030 5.4 Asia Pacific 5.4.1 Asia Pacific Cancer Biological Therapy Sales Value, 2019-2030 5.4.2 Asia Pacific Cancer Biological Therapy Sales Value by Country (%), 2023 VS 2030 5.5 South America 5.5.1 South America Cancer Biological Therapy Sales Value, 2019-2030 5.5.2 South America Cancer Biological Therapy Sales Value by Country (%), 2023 VS 2030 5.6 Middle East & Africa 5.6.1 Middle East & Africa Cancer Biological Therapy Sales Value, 2019-2030 5.6.2 Middle East & Africa Cancer Biological Therapy Sales Value by Country (%), 2023 VS 2030 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Cancer Biological Therapy Sales Value Growth Trends, 2019 VS 2023 VS 2030 6.2 Key Countries/Regions Cancer Biological Therapy Sales Value 6.3 United States 6.3.1 United States Cancer Biological Therapy Sales Value, 2019-2030 6.3.2 United States Cancer Biological Therapy Sales Value by Type (%), 2023 VS 2030 6.3.3 United States Cancer Biological Therapy Sales Value by Application, 2023 VS 2030 6.4 Europe 6.4.1 Europe Cancer Biological Therapy Sales Value, 2019-2030 6.4.2 Europe Cancer Biological Therapy Sales Value by Type (%), 2023 VS 2030 6.4.3 Europe Cancer Biological Therapy Sales Value by Application, 2023 VS 2030 6.5 China 6.5.1 China Cancer Biological Therapy Sales Value, 2019-2030 6.5.2 China Cancer Biological Therapy Sales Value by Type (%), 2023 VS 2030 6.5.3 China Cancer Biological Therapy Sales Value by Application, 2023 VS 2030 6.6 Japan 6.6.1 Japan Cancer Biological Therapy Sales Value, 2019-2030 6.6.2 Japan Cancer Biological Therapy Sales Value by Type (%), 2023 VS 2030 6.6.3 Japan Cancer Biological Therapy Sales Value by Application, 2023 VS 2030 6.7 South Korea 6.7.1 South Korea Cancer Biological Therapy Sales Value, 2019-2030 6.7.2 South Korea Cancer Biological Therapy Sales Value by Type (%), 2023 VS 2030 6.7.3 South Korea Cancer Biological Therapy Sales Value by Application, 2023 VS 2030 6.8 Southeast Asia 6.8.1 Southeast Asia Cancer Biological Therapy Sales Value, 2019-2030 6.8.2 Southeast Asia Cancer Biological Therapy Sales Value by Type (%), 2023 VS 2030 6.8.3 Southeast Asia Cancer Biological Therapy Sales Value by Application, 2023 VS 2030 6.9 India 6.9.1 India Cancer Biological Therapy Sales Value, 2019-2030 6.9.2 India Cancer Biological Therapy Sales Value by Type (%), 2023 VS 2030 6.9.3 India Cancer Biological Therapy Sales Value by Application, 2023 VS 2030 7 Company Profiles 7.1 ELI Lilly 7.1.1 ELI Lilly Profile 7.1.2 ELI Lilly Main Business 7.1.3 ELI Lilly Cancer Biological Therapy Products, Services and Solutions 7.1.4 ELI Lilly Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.1.5 ELI Lilly Recent Developments 7.2 Sanofi 7.2.1 Sanofi Profile 7.2.2 Sanofi Main Business 7.2.3 Sanofi Cancer Biological Therapy Products, Services and Solutions 7.2.4 Sanofi Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.2.5 Sanofi Recent Developments 7.3 Merck 7.3.1 Merck Profile 7.3.2 Merck Main Business 7.3.3 Merck Cancer Biological Therapy Products, Services and Solutions 7.3.4 Merck Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.3.5 Bayer Recent Developments 7.4 Bayer 7.4.1 Bayer Profile 7.4.2 Bayer Main Business 7.4.3 Bayer Cancer Biological Therapy Products, Services and Solutions 7.4.4 Bayer Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.4.5 Bayer Recent Developments 7.5 Roche 7.5.1 Roche Profile 7.5.2 Roche Main Business 7.5.3 Roche Cancer Biological Therapy Products, Services and Solutions 7.5.4 Roche Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.5.5 Roche Recent Developments 7.6 Novartis International 7.6.1 Novartis International Profile 7.6.2 Novartis International Main Business 7.6.3 Novartis International Cancer Biological Therapy Products, Services and Solutions 7.6.4 Novartis International Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.6.5 Novartis International Recent Developments 7.7 Pfizer 7.7.1 Pfizer Profile 7.7.2 Pfizer Main Business 7.7.3 Pfizer Cancer Biological Therapy Products, Services and Solutions 7.7.4 Pfizer Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.7.5 Pfizer Recent Developments 7.8 Bristol-Myers Squibb 7.8.1 Bristol-Myers Squibb Profile 7.8.2 Bristol-Myers Squibb Main Business 7.8.3 Bristol-Myers Squibb Cancer Biological Therapy Products, Services and Solutions 7.8.4 Bristol-Myers Squibb Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.8.5 Bristol-Myers Squibb Recent Developments 7.9 Seattle Genetics 7.9.1 Seattle Genetics Profile 7.9.2 Seattle Genetics Main Business 7.9.3 Seattle Genetics Cancer Biological Therapy Products, Services and Solutions 7.9.4 Seattle Genetics Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.9.5 Seattle Genetics Recent Developments 7.10 Amgen 7.10.1 Amgen Profile 7.10.2 Amgen Main Business 7.10.3 Amgen Cancer Biological Therapy Products, Services and Solutions 7.10.4 Amgen Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.10.5 Amgen Recent Developments 7.11 Takeda Pharmaceuticals 7.11.1 Takeda Pharmaceuticals Profile 7.11.2 Takeda Pharmaceuticals Main Business 7.11.3 Takeda Pharmaceuticals Cancer Biological Therapy Products, Services and Solutions 7.11.4 Takeda Pharmaceuticals Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.11.5 Takeda Pharmaceuticals Recent Developments 7.12 GlaxoSmithKline 7.12.1 GlaxoSmithKline Profile 7.12.2 GlaxoSmithKline Main Business 7.12.3 GlaxoSmithKline Cancer Biological Therapy Products, Services and Solutions 7.12.4 GlaxoSmithKline Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.12.5 GlaxoSmithKline Recent Developments 7.13 Spectrum Pharmaceuticals 7.13.1 Spectrum Pharmaceuticals Profile 7.13.2 Spectrum Pharmaceuticals Main Business 7.13.3 Spectrum Pharmaceuticals Cancer Biological Therapy Products, Services and Solutions 7.13.4 Spectrum Pharmaceuticals Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.13.5 Spectrum Pharmaceuticals Recent Developments 7.14 Celgene Corporation 7.14.1 Celgene Corporation Profile 7.14.2 Celgene Corporation Main Business 7.14.3 Celgene Corporation Cancer Biological Therapy Products, Services and Solutions 7.14.4 Celgene Corporation Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.14.5 Celgene Corporation Recent Developments 7.15 AstraZeneca, Plc. 7.15.1 AstraZeneca, Plc. Profile 7.15.2 AstraZeneca, Plc. Main Business 7.15.3 AstraZeneca, Plc. Cancer Biological Therapy Products, Services and Solutions 7.15.4 AstraZeneca, Plc. Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.15.5 AstraZeneca, Plc. Recent Developments 7.16 Otsuka 7.16.1 Otsuka Profile 7.16.2 Otsuka Main Business 7.16.3 Otsuka Cancer Biological Therapy Products, Services and Solutions 7.16.4 Otsuka Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.16.5 Otsuka Recent Developments 7.17 Eisai 7.17.1 Eisai Profile 7.17.2 Eisai Main Business 7.17.3 Eisai Cancer Biological Therapy Products, Services and Solutions 7.17.4 Eisai Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.17.5 Eisai Recent Developments 7.18 Abbvie 7.18.1 Abbvie Profile 7.18.2 Abbvie Main Business 7.18.3 Abbvie Cancer Biological Therapy Products, Services and Solutions 7.18.4 Abbvie Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.18.5 Abbvie Recent Developments 7.19 Incyte 7.19.1 Incyte Profile 7.19.2 Incyte Main Business 7.19.3 Incyte Cancer Biological Therapy Products, Services and Solutions 7.19.4 Incyte Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.19.5 Incyte Recent Developments 8 Industry Chain Analysis 8.1 Cancer Biological Therapy Industrial Chain 8.2 Cancer Biological Therapy Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Cancer Biological Therapy Sales Model 8.5.2 Sales Channel 8.5.3 Cancer Biological Therapy Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
SummaryCancer biological therapy is a type of treatment that uses the body's immune system to kill cancer cells. Cancer biological therapy can treat many types of cancer. It can prevent or slow tumor growth and prevent the spread of cancer. When cancer spreads, it's called metastatic cancer. Table of Contents1 Market Overview1.1 Cancer Biological Therapy Product Introduction 1.2 Global Cancer Biological Therapy Market Size Forecast 1.3 Cancer Biological Therapy Market Trends & Drivers 1.3.1 Cancer Biological Therapy Industry Trends 1.3.2 Cancer Biological Therapy Market Drivers & Opportunity 1.3.3 Cancer Biological Therapy Market Challenges 1.3.4 Cancer Biological Therapy Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Cancer Biological Therapy Players Revenue Ranking (2023) 2.2 Global Cancer Biological Therapy Revenue by Company (2019-2024) 2.3 Key Companies Cancer Biological Therapy Manufacturing Base Distribution and Headquarters 2.4 Key Companies Cancer Biological Therapy Product Offered 2.5 Key Companies Time to Begin Mass Production of Cancer Biological Therapy 2.6 Cancer Biological Therapy Market Competitive Analysis 2.6.1 Cancer Biological Therapy Market Concentration Rate (2019-2024) 2.6.2 Global 5 and 10 Largest Companies by Cancer Biological Therapy Revenue in 2023 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biological Therapy as of 2023) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Monoclonal Antibodies 3.1.2 Vaccines 3.1.3 Cancer Growth Blockers 3.1.4 Blood Cell Growth Factors 3.2 Global Cancer Biological Therapy Sales Value by Type 3.2.1 Global Cancer Biological Therapy Sales Value by Type (2019 VS 2023 VS 2030) 3.2.2 Global Cancer Biological Therapy Sales Value, by Type (2019-2030) 3.2.3 Global Cancer Biological Therapy Sales Value, by Type (%) (2019-2030) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Hospitals 4.1.2 Diagnostic Laboratories 4.1.3 Research & Academic Laboratories 4.1.4 Pharmaceutical & Biotechnology Companies 4.2 Global Cancer Biological Therapy Sales Value by Application 4.2.1 Global Cancer Biological Therapy Sales Value by Application (2019 VS 2023 VS 2030) 4.2.2 Global Cancer Biological Therapy Sales Value, by Application (2019-2030) 4.2.3 Global Cancer Biological Therapy Sales Value, by Application (%) (2019-2030) 5 Segmentation by Region 5.1 Global Cancer Biological Therapy Sales Value by Region 5.1.1 Global Cancer Biological Therapy Sales Value by Region: 2019 VS 2023 VS 2030 5.1.2 Global Cancer Biological Therapy Sales Value by Region (2019-2024) 5.1.3 Global Cancer Biological Therapy Sales Value by Region (2025-2030) 5.1.4 Global Cancer Biological Therapy Sales Value by Region (%), (2019-2030) 5.2 North America 5.2.1 North America Cancer Biological Therapy Sales Value, 2019-2030 5.2.2 North America Cancer Biological Therapy Sales Value by Country (%), 2023 VS 2030 5.3 Europe 5.3.1 Europe Cancer Biological Therapy Sales Value, 2019-2030 5.3.2 Europe Cancer Biological Therapy Sales Value by Country (%), 2023 VS 2030 5.4 Asia Pacific 5.4.1 Asia Pacific Cancer Biological Therapy Sales Value, 2019-2030 5.4.2 Asia Pacific Cancer Biological Therapy Sales Value by Country (%), 2023 VS 2030 5.5 South America 5.5.1 South America Cancer Biological Therapy Sales Value, 2019-2030 5.5.2 South America Cancer Biological Therapy Sales Value by Country (%), 2023 VS 2030 5.6 Middle East & Africa 5.6.1 Middle East & Africa Cancer Biological Therapy Sales Value, 2019-2030 5.6.2 Middle East & Africa Cancer Biological Therapy Sales Value by Country (%), 2023 VS 2030 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Cancer Biological Therapy Sales Value Growth Trends, 2019 VS 2023 VS 2030 6.2 Key Countries/Regions Cancer Biological Therapy Sales Value 6.3 United States 6.3.1 United States Cancer Biological Therapy Sales Value, 2019-2030 6.3.2 United States Cancer Biological Therapy Sales Value by Type (%), 2023 VS 2030 6.3.3 United States Cancer Biological Therapy Sales Value by Application, 2023 VS 2030 6.4 Europe 6.4.1 Europe Cancer Biological Therapy Sales Value, 2019-2030 6.4.2 Europe Cancer Biological Therapy Sales Value by Type (%), 2023 VS 2030 6.4.3 Europe Cancer Biological Therapy Sales Value by Application, 2023 VS 2030 6.5 China 6.5.1 China Cancer Biological Therapy Sales Value, 2019-2030 6.5.2 China Cancer Biological Therapy Sales Value by Type (%), 2023 VS 2030 6.5.3 China Cancer Biological Therapy Sales Value by Application, 2023 VS 2030 6.6 Japan 6.6.1 Japan Cancer Biological Therapy Sales Value, 2019-2030 6.6.2 Japan Cancer Biological Therapy Sales Value by Type (%), 2023 VS 2030 6.6.3 Japan Cancer Biological Therapy Sales Value by Application, 2023 VS 2030 6.7 South Korea 6.7.1 South Korea Cancer Biological Therapy Sales Value, 2019-2030 6.7.2 South Korea Cancer Biological Therapy Sales Value by Type (%), 2023 VS 2030 6.7.3 South Korea Cancer Biological Therapy Sales Value by Application, 2023 VS 2030 6.8 Southeast Asia 6.8.1 Southeast Asia Cancer Biological Therapy Sales Value, 2019-2030 6.8.2 Southeast Asia Cancer Biological Therapy Sales Value by Type (%), 2023 VS 2030 6.8.3 Southeast Asia Cancer Biological Therapy Sales Value by Application, 2023 VS 2030 6.9 India 6.9.1 India Cancer Biological Therapy Sales Value, 2019-2030 6.9.2 India Cancer Biological Therapy Sales Value by Type (%), 2023 VS 2030 6.9.3 India Cancer Biological Therapy Sales Value by Application, 2023 VS 2030 7 Company Profiles 7.1 ELI Lilly 7.1.1 ELI Lilly Profile 7.1.2 ELI Lilly Main Business 7.1.3 ELI Lilly Cancer Biological Therapy Products, Services and Solutions 7.1.4 ELI Lilly Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.1.5 ELI Lilly Recent Developments 7.2 Sanofi 7.2.1 Sanofi Profile 7.2.2 Sanofi Main Business 7.2.3 Sanofi Cancer Biological Therapy Products, Services and Solutions 7.2.4 Sanofi Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.2.5 Sanofi Recent Developments 7.3 Merck 7.3.1 Merck Profile 7.3.2 Merck Main Business 7.3.3 Merck Cancer Biological Therapy Products, Services and Solutions 7.3.4 Merck Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.3.5 Bayer Recent Developments 7.4 Bayer 7.4.1 Bayer Profile 7.4.2 Bayer Main Business 7.4.3 Bayer Cancer Biological Therapy Products, Services and Solutions 7.4.4 Bayer Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.4.5 Bayer Recent Developments 7.5 Roche 7.5.1 Roche Profile 7.5.2 Roche Main Business 7.5.3 Roche Cancer Biological Therapy Products, Services and Solutions 7.5.4 Roche Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.5.5 Roche Recent Developments 7.6 Novartis International 7.6.1 Novartis International Profile 7.6.2 Novartis International Main Business 7.6.3 Novartis International Cancer Biological Therapy Products, Services and Solutions 7.6.4 Novartis International Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.6.5 Novartis International Recent Developments 7.7 Pfizer 7.7.1 Pfizer Profile 7.7.2 Pfizer Main Business 7.7.3 Pfizer Cancer Biological Therapy Products, Services and Solutions 7.7.4 Pfizer Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.7.5 Pfizer Recent Developments 7.8 Bristol-Myers Squibb 7.8.1 Bristol-Myers Squibb Profile 7.8.2 Bristol-Myers Squibb Main Business 7.8.3 Bristol-Myers Squibb Cancer Biological Therapy Products, Services and Solutions 7.8.4 Bristol-Myers Squibb Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.8.5 Bristol-Myers Squibb Recent Developments 7.9 Seattle Genetics 7.9.1 Seattle Genetics Profile 7.9.2 Seattle Genetics Main Business 7.9.3 Seattle Genetics Cancer Biological Therapy Products, Services and Solutions 7.9.4 Seattle Genetics Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.9.5 Seattle Genetics Recent Developments 7.10 Amgen 7.10.1 Amgen Profile 7.10.2 Amgen Main Business 7.10.3 Amgen Cancer Biological Therapy Products, Services and Solutions 7.10.4 Amgen Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.10.5 Amgen Recent Developments 7.11 Takeda Pharmaceuticals 7.11.1 Takeda Pharmaceuticals Profile 7.11.2 Takeda Pharmaceuticals Main Business 7.11.3 Takeda Pharmaceuticals Cancer Biological Therapy Products, Services and Solutions 7.11.4 Takeda Pharmaceuticals Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.11.5 Takeda Pharmaceuticals Recent Developments 7.12 GlaxoSmithKline 7.12.1 GlaxoSmithKline Profile 7.12.2 GlaxoSmithKline Main Business 7.12.3 GlaxoSmithKline Cancer Biological Therapy Products, Services and Solutions 7.12.4 GlaxoSmithKline Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.12.5 GlaxoSmithKline Recent Developments 7.13 Spectrum Pharmaceuticals 7.13.1 Spectrum Pharmaceuticals Profile 7.13.2 Spectrum Pharmaceuticals Main Business 7.13.3 Spectrum Pharmaceuticals Cancer Biological Therapy Products, Services and Solutions 7.13.4 Spectrum Pharmaceuticals Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.13.5 Spectrum Pharmaceuticals Recent Developments 7.14 Celgene Corporation 7.14.1 Celgene Corporation Profile 7.14.2 Celgene Corporation Main Business 7.14.3 Celgene Corporation Cancer Biological Therapy Products, Services and Solutions 7.14.4 Celgene Corporation Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.14.5 Celgene Corporation Recent Developments 7.15 AstraZeneca, Plc. 7.15.1 AstraZeneca, Plc. Profile 7.15.2 AstraZeneca, Plc. Main Business 7.15.3 AstraZeneca, Plc. Cancer Biological Therapy Products, Services and Solutions 7.15.4 AstraZeneca, Plc. Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.15.5 AstraZeneca, Plc. Recent Developments 7.16 Otsuka 7.16.1 Otsuka Profile 7.16.2 Otsuka Main Business 7.16.3 Otsuka Cancer Biological Therapy Products, Services and Solutions 7.16.4 Otsuka Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.16.5 Otsuka Recent Developments 7.17 Eisai 7.17.1 Eisai Profile 7.17.2 Eisai Main Business 7.17.3 Eisai Cancer Biological Therapy Products, Services and Solutions 7.17.4 Eisai Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.17.5 Eisai Recent Developments 7.18 Abbvie 7.18.1 Abbvie Profile 7.18.2 Abbvie Main Business 7.18.3 Abbvie Cancer Biological Therapy Products, Services and Solutions 7.18.4 Abbvie Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.18.5 Abbvie Recent Developments 7.19 Incyte 7.19.1 Incyte Profile 7.19.2 Incyte Main Business 7.19.3 Incyte Cancer Biological Therapy Products, Services and Solutions 7.19.4 Incyte Cancer Biological Therapy Revenue (US$ Million) & (2019-2024) 7.19.5 Incyte Recent Developments 8 Industry Chain Analysis 8.1 Cancer Biological Therapy Industrial Chain 8.2 Cancer Biological Therapy Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Cancer Biological Therapy Sales Model 8.5.2 Sales Channel 8.5.3 Cancer Biological Therapy Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療）の最新刊レポート
QYResearch社の医療分野での最新刊レポート
本レポートと同じKEY WORD（）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|